Cargando…

Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis?

BACKGROUND: Ventricular tachycardia (VT) can persist following placement of a left ventricular assist device (LVAD). The optimal management strategy for VT during the peri-LVAD period is unknown. CASE PRESENTATIONS: Two case reports are presented that describe epicardial and endocardial VT ablation...

Descripción completa

Detalles Bibliográficos
Autores principales: McIlvennan, Colleen K., Babu, Ashok N., Brieke, Andreas, Ambardekar, Amrut V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827214/
https://www.ncbi.nlm.nih.gov/pubmed/27067868
http://dx.doi.org/10.1186/s13019-016-0451-x
Descripción
Sumario:BACKGROUND: Ventricular tachycardia (VT) can persist following placement of a left ventricular assist device (LVAD). The optimal management strategy for VT during the peri-LVAD period is unknown. CASE PRESENTATIONS: Two case reports are presented that describe epicardial and endocardial VT ablation performed during LVAD placement. Subsequently, both patients developed LVAD thrombosis, a known and dreaded complication of LVADs, requiring re-operation. CONCLUSIONS: While LVAD thrombosis is likely multifactorial and remains an area of active research, these two cases should increase awareness of the possible risks of VT ablation—especially endocardial ablation—during LVAD placement. Further research is needed to understand the effects of VT ablation during the peri-LVAD period.